Consumer Discretionary

Nike’s Successful Air Max DN Launch Gets Off On The Right Foot, Says Analyst

Wedbush analyst Tom Nikic reiterates an Outperform rating on the shares of Nike Inc (NYSE:NKE) with a price target of $115. While NKE shares have languished recently due to investor frustration over lack of exciting new products, the analyst notes the company got much-needed good news on their annual “Air Max Day” celebration. The analyst points to the new Air Max DN model that debuted in multiple colorways, and completely sold out on Nike.com. This product, according to the analyst, is important because the company has been off its game from a product development perspective in recent years, so it desperately needs a hot new product to drive brand heat. Also, in an increasingly competitive sneaker environment where rivals are innovating with foam-based cushioning, Nike’s specialization with air-based cushioning systems is a key point of differentiation versus peers, notes the analyst. Thus, the analyst sees the successful initial launch as a positive data […]

Nike’s Successful Air Max DN Launch Gets Off On The Right Foot, Says Analyst Read Post »

CFRA Keeps Buy Opinion On Shares Of Amazon.com, Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Today, AMZN raised its investment in AI startup Anthropic by $2.75 billion, bringing its total stake to $4 billion after an initial $1.25 billion investment last September. As part of this partnership, Anthropic will use Amazon Web Services (AWS) as its primary cloud provider and leverage AWS’s Trainium and Inferentia chips to build, train, and deploy future foundational AI models. These models are now available on Amazon’s Bedrock platform, which also hosts large language models from other major AI companies like AI21 Labs, Cohere, Meta, Mistral AI, and Stability AI, as well as Amazon’s own models. Earlier this month, Anthropic released the Claude 3 model family, which includes Claude 3 Haiku, Claude 3 Sonnet, and Claude 3 Opus. Claude 3 Opus is the most intelligent chatbot of

CFRA Keeps Buy Opinion On Shares Of Amazon.com, Inc. Read Post »

Walmart Hits Pause Button on Vizio Deal After ‘Informal’ Antitrust Talks

Walmart Inc. (WMT) and Vizio Corp. (VZIO) said late Wednesday they are going to refile paperwork related to their proposed merger after the retail giant held “informal” antitrust talks with the Federal Trade Commission and the Justice Department. Walmart in a securities filing said it notified the agencies that it will withdraw and refile a premerger notification “in order to give the antitrust agencies additional time to review the proposed transaction.” The notification was originally sent on Feb. 26, and the refile is expected on Friday. Shares of Walmart were down a fraction in the extended session Wednesday, and shares of Vizio fell 1%.

Walmart Hits Pause Button on Vizio Deal After ‘Informal’ Antitrust Talks Read Post »

Tesla Pushes to Increase Use of ‘Full Self-Driving’ Software as Vehicle Sales Cool — WSJ

By Ryan Felton and Rebecca Elliott Tesla is stepping up promotion of its driver-assistance technology, called “Full-Self Driving Capability,” seeking to expand use of the revenue-generating software feature as it confronts the prospect of lower growth in vehicle deliveries this year. Elon Musk, Tesla’s chief executive, told employees this week in an internal email that customers must receive a test drive using the technology before they receive a car. The system is an advanced version of the company’s Autopilot technology, which is available on all new Teslas and is designed to help with driving tasks like steering and lane changes. Full Self-Driving, an upgrade available for $12,000 up front or $199 a month as a subscription service, includes features that can navigate cars through city streets. “I know this will slow down the delivery process, but it is nonetheless a hard requirement,” Musk said in the employee email, which was

Tesla Pushes to Increase Use of ‘Full Self-Driving’ Software as Vehicle Sales Cool — WSJ Read Post »

Amazon Pharmacy Reaping Benefits of Demand for Anti-Obesity Drugs, Executive Says

Amazon.com’s (AMZN) online pharmacy is reaping the benefits of demand for anti-obesity drugs in the US, the Financial Times reported, citing John Love, the head of the business. Drugs such as Eli Lilly’s (LLY) Zepbound and Novo Nordisk’s (NVO) Wegovy would create “a lot of revenue” for Amazon Pharmacy, said Love, the division’s general manager and vice president, according to the report. Both drugs are available directly through Amazon’s website, the FT said. Earlier in March, Eli Lilly and Amazon Pharmacy partnered to deliver widely used prescription drugs through the LillyDirect consumer services. The drugs include Eli Lilly’s obesity, diabetes and migraine headache medicines. Amazon said Tuesday it started same-day delivery for prescription medication in New York and greater Los Angeles using e-bikes, electric vans and drones.

Amazon Pharmacy Reaping Benefits of Demand for Anti-Obesity Drugs, Executive Says Read Post »

Scroll to Top